[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
This Week in JAMA
November 3, 2004

This Week in JAMA

JAMA. 2004;292(17):2049. doi:10.1001/jama.292.17.2049

Annual influenza revaccination of institutionalized elderly individuals is associated with improved survival, but whether a mortality benefit exists for persons living in the community is not clear. Voordouw and colleagues investigated the effect of annual influenza revaccination vs no vaccination on mortality in community-dwelling elderly individuals aged 65 years and older. They found that annual influenza revaccination was associated with a significant mortality reduction among those aged 70 years and older and those with and without chronic comorbidities.

See Article

Professional guidelines recommend early invasive management (cardiac catheterization within 48 hours of presentation) for high-risk patients with non–ST-segment elevation acute coronary syndromes (NSTE ACS). However, it is not known whether this recommendation is reflected in clinical practice. Bhatt and colleagues conducted a multicenter observational study evaluating the care and outcomes for patients at high-risk of NSTE ACS and report use and predictors of early invasive management and in-hospital mortality. They found fewer than half the patients had early catheterization. Patients who did had few significant comorbidities, were likely to be cared for by cardiologists, and had lower in-hospital mortality.